AAV9-mediated erythropoietin gene transfer to the rat brain in a rat model of Parkinson's disease

被引：0
|
作者：
Xue, Y. -Q. [1 ]
Tatom, J. B. [2 ]
Jiang, L. -X. [3 ]
Zhao, L. -R. [4 ,5 ]
Klein, R. L. [2 ,5 ]
Duan, W. -M. [1 ,5 ]
机构：
[1] Louisiana State Univ, Hlth Sci Ctr, Dept Cellular Biol & Anat, Shreveport, LA 71105 USA
[2] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol Toxicol & Neurosci, Shreveport, LA 71105 USA
[3] Vector Gene Technol Co, Beijing, Peoples R China
[4] Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, Shreveport, LA 71105 USA
[5] Louisiana State Univ, Hlth Sci Ctr, Gene Therapy Program, Shreveport, LA 71105 USA
来源：
CELL TRANSPLANTATION | 2008年 / 17卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
引用
收藏
页码：486 / 486
页数：1
相关论文
共 50 条
  • [21] AAV9-mediated gene therapy in a knock-in mouse model of infantile neuroaxonal dystrophy
    Whaler, S.
    Geard, A. F.
    Poupon-Bejuit, L.
    Massaro, G.
    Hughes, M. P.
    Lalji, K.
    Waddington, S. N.
    Kurian, M. A.
    Rahim, A. A.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A12 - A12
  • [22] Effects of Carbamylated Erythropoietin Fusion Protein on Parkinson's Disease Model of Rat
    Tayra, J. T.
    Kameda, M.
    Yasuhara, Y.
    Wang, F.
    Kikuchi, Y.
    Liang, H.
    Shinko, A.
    Wakamori, T.
    Miyoshi, Y.
    Date, I.
    CELL TRANSPLANTATION, 2011, 20 (04) : 588 - 588
  • [23] AAV-GAD gene for rat models of neuropathic pain and Parkinson's disease
    Kim, J.
    Yoon, Y. S.
    Lee, H.
    Chang, J. W.
    RECONSTRUCTIVE NEUROSURGERY, 2008, 101 : 99 - +
  • [24] Astrocyte-Restricted Gene Silencing Improves the Safety of AAV9-Mediated Gene Therapy for Alexander Disease
    Boonying, Wassamon
    Gao, Guangping
    Xie, Jun
    MOLECULAR THERAPY, 2022, 30 (04) : 208 - 208
  • [25] Gene therapy with AAV2-CDNF provides functional benefits in a rat model of Parkinson's disease
    Back, Susanne
    Peranen, Johan
    Galli, Emilia
    Pulkkila, Paivi
    Lonka-Nevalaita, Liina
    Tamminen, Tuulia
    Voutilainen, Merja H.
    Raasmaja, Atso
    Saarma, Mart
    Mannisto, Pekka T.
    Tuominen, Raimo K.
    BRAIN AND BEHAVIOR, 2013, 3 (02): : 75 - 88
  • [26] Adenovirus-mediated th gene therapy of Parkinson's disease in experimental rat model
    Xu, DH
    Xu, LF
    Shi, CG
    Zhuo, M
    Cao, L
    Liu, XY
    Zheng, ZC
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2000, 32 (04): : 347 - 350
  • [27] Human interleukin-10 gene transfer is protective in a rat model of Parkinson's disease
    Johnston, Louisa C.
    Su, Xiaomin
    Maguire-Zeiss, Kathleen
    Horovitz, Karen
    Ankoudinova, Irina
    Guschin, Dmitry
    Hadaczek, Piotr
    Federoff, Howard J.
    Bankiewicz, Krystof
    Forsayeth, John
    MOLECULAR THERAPY, 2008, 16 (08) : 1392 - 1399
  • [28] Intravenous AAV9-mediated gene therapy ameliorates neuronal disease of mucopolysaccharidosis type II (MPSII)
    Miwa, S.
    Shimada, Y.
    Higuchi, T.
    Kobayashi, H.
    Ohashi, T.
    HUMAN GENE THERAPY, 2018, 29 (12) : A125 - A126
  • [29] Development of an AAV9-mediated gene therapy for hereditary spastic paraplegia 47
    Scarrott, J. M.
    Coldicott, I.
    Davies, A.
    Hirst, J.
    Karyka, E.
    Bauer, C.
    Azzouz, M.
    HUMAN GENE THERAPY, 2019, 30 (08) : A18 - A18
  • [30] Fasudil Promotes α-Synuclein Clearance in an AAV-Mediated α-Synuclein Rat Model of Parkinson's Disease by Autophagy Activation
    Yang, Yu-Jie
    Bu, Lu-Lu
    Shen, Cong
    Ge, Jing-Jie
    He, Shu-Jin
    Yu, Hui-Ling
    Tang, Yi-Lin
    Jue, Zhao
    Sun, Yi-Min
    Yu, Wen-Bo
    Zuo, Chuan-Tao
    Wu, Jian-Jun
    Wang, Jian
    Liu, Feng Tao
    JOURNAL OF PARKINSONS DISEASE, 2020, 10 (03) : 969 - 979
12345